The transgenic construct contains a loxP-flanked full length human dystrophin gene modified by the deletion of the Hinge 2 region through repeat 15 to generate a micro-dystrophin cDNA under the control of the rat cardiac muscle specific alpha myosin (Myh6 or alpha-MHC) promoter. (J:94077)